Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2020-04-13 | 2020-04-27 | 111936 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2020-04-13 | 2020-04-27 | 111943 |
| APO-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-17 | 2017-06-23 | 3175 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-20 | 2017-07-11 | 3529 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2017-05-02 | 2017-06-28 | 8723 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2017-05-16 | 2017-10-27 | 10434 |
| APO-PAROXETINE | 10MG | TABLET | Resolved | 2023-09-22 | 2023-10-06 | 205006 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2023-09-22 | 2023-10-06 | 205018 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2018-05-08 | 2018-07-17 | 48850 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2018-05-08 | 2018-09-11 | 48854 |
| APO-PAROXETINE | 10MG | TABLET | Resolved | 2018-05-31 | 2018-07-18 | 50968 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2018-06-04 | 2018-07-25 | 51194 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2018-11-30 | 2018-12-20 | 68236 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2018-08-09 | 2018-11-19 | 57802 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2018-10-11 | 2018-11-22 | 63800 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-08 | 2020-09-04 | 119765 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-23 | 2020-09-04 | 120985 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-03-04 | 2022-03-24 | 156036 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-05-13 | 2022-06-06 | 160604 |
| APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-05-27 | 2022-08-11 | 161451 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |